Immunotherapy for prostate cancer Turkey
Last updated: 8/16/2024
Immunotherapy for prostate cancer in Turkey: Our Best Clinics and Costs 2024
6 Recent Immunotherapy for prostate cancer Reviews in Turkey: Check Real Patient Experience
Ramona • Immunotherapy Romania Jun 17, 2021
A big thank you to all!!
I am so impressed by the dedication and professionalism of the medical team of Anadolu!!Their fast acting, applying right procedures, the care and attention they give to pacients and family truly bring honor to this profession!!We felt that people and their lives are valued for real, before verything else,unlike in other places!!A big thank you to all!!
About Bookimed service
I am extremely sattisfied with the support.I really need to mention the consultant Teodora, an amazing ptofessional and person, who gave us the best support through a vry hard situation!Our thanks from the heart!!!Noura Ramadan • Uterine cancer Kuwait Jul 2, 2024
I'm really grateful
Big thanks for bookimed. And special thanks for doctor Ahmed Khaled for helping us to choose Anadulo medical centre. Thanks a lot for everything.I'm really grateful.
About Bookimed service
Big thanks for bookimed. And special thanks for doctor Ahmed Khaled for helping us to choose Anadulo medical centre. Thanks a lot for everything.I'm really gratefulВалерий • Melanoma Ukraine May 21, 2019
"I can only say thanks to your company and Katerina
Good evening. I can only say thanks to your company and Katerina. Thank you so much for your help and support. The impression about the clinic itself was not very, often made nervous, dragged time, I can’t say anything about the professor either. Five minutes talk for $ 120 a bit too much. The clinic itself is not bad, in my opinion, a lot of clients have simply gathered and cannot cope with such volume, and here we are not talking about the desire to help, just money. How to undertake, I can say that robots need to take as much as possible so that they can cope with it, otherwise it negatively affects their reputation. Thank you again
Rubina Siddique • Ovarian cancer Pakistan Apr 7, 2024
Лариса Novichkov • Melanoma Ukraine May 8, 2019
Immunotherapy for prostate cancer Overview in Turkey
Takeaways
Related procedures & Costs
How it works
What to expect
Pros & Cons
Benefits
Payment
patients recommend -
91%
Surgery Time - 2
hours
Stay in the country -
1
day
Rehabilitation - 1
day
Anesthesia - Local anesthesia
Verified patient reviews -
6
Requests processed - 46119
Bookimed fees - $0
Types of Immunotherapy
- Biological therapy - from $2000
This therapy uses living organisms to treat disease by stimulating the body"s own immune system.
- Immunotherapy - from $1253
This therapy boosts the body"s natural defenses to fight diseases like cancer, bringing less side effects.
-
This therapy, employing a TB vaccine, aids in bladder cancer treatment, through direct insertion into the bladder.
- Immunotherapy with (Pembolizumab) - from $7300
The therapy is a treatment enhancing the body"s immune system to fight cancer, using a drug highly targeted and effective.
- Immunotherapy for lung cancer - from $10000
This therapy boosts your body"s natural defenses to fight lung cancer, using substances made by the body itself.
- Immunotherapy for breast cancer - from $10000
This therapy boosts your immune system to fight and eradicate breast cancer cells effectively.
- Immunotherapy for kidney cancer - from $10000
This therapy boosts the body"s natural defenses, often prolonging life in kidney cancer patients.
- CAR T-cell therapy - from $55000
This therapy modifies patient"s cells to combat cancer, merging immunology and genetics. It"s precise, powerful, potentially one-off treatment.
- Sarcoma Immunotherapy - from $3600
This therapy boosts the body"s immune system to fight cancerous tumors, offering promising, targeted treatment for sarcoma.
How to find best solution with Bookimed?
Check available options for your case on the website.
Request a free consultation with documents assessment.
Download your medical records and describe your needs.
Receive customized free treatment plans with prices and details.
Compare them and finalize your choice.
Agree the date for your upcoming clinic visit.
Arrive and pay at the clinic. Bookimed fees are $0 for you.
From start to finish, the Bookimed coordinator keeps you safe and comfortable during your medical journey.
💚Your benefits with Bookimed
100% free, non-binding assessment of your medical records
Instant FREE personalized treatment plans to make the right choice
Expert guidance in choosing the perfect Oncology doctor and clinic.
Special packages and exclusive prices for our patients.
24/7 Bookimed guidance at no cost, guaranteed.
Hassle-free translation of your medical documents for clinics.
Bookimed's multilingual team ensures comfortable communication.
Bookimed ensures transparent and secure payments. Patients pay at the clinic with no additional fees.
Available Payment Methods:
How to Secure an Appointment:
- Documents: Passport and ticket copies.
- or
- Deposit:
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
For more information, see our
Payment Policy
Step-by-Step Roadmap
Day 1
- Arrive at the medical facility for check-in.
- Meet with the oncologist for a consultation.
- Undergo necessary blood tests.
Day 2
- Get results from the blood tests.
- Prepare for the Immunotherapy treatment.
Day 3
- Begin the Immunotherapy treatment.
- The process takes about 3 hours.
- No anesthesia is required for this procedure.
Day 4
- Post-treatment consultation with the oncologist.
- Stay in the clinic for observation.
Week 1
- Start of the recovery period.
- Regular follow-up with the oncologist.
- Start light physical activities.
Week 2
- Progress to moderate physical activities.
- Continue the regular follow-up with the oncologist.
Week 3
- Return to work and other daily activities.
- Follow-up with the oncologist for progress check.
Week 4
- Resume sports and other strenuous activities.
- Continue regular follow-up with the oncologist.
Please note that each patient"s experience with Immunotherapy for prostate cancer can vary. The above timeline provides a general guideline but individual cases may differ.
What patients like:
- Cost. The Immunotherapy for prostate cancer cost in Turkey ranges from $10000 to $13000. This comparatively cheaper cost attracts many patients globally.
- Doctor’s professionalism. Patients appreciate the high level of doctors' professionalism. Most of them have international certifications and memberships in professional organizations.
- Service level. Patients are generally satisfied with the high service level, including personalized care and state-of-the-art facilities.
- Immunotherapy for prostate cancer efficacy. The modern techniques used in Turkey often result in positive outcomes, making patients appreciate the effectiveness of the treatment.
- Logistics. Patients enjoy the easy logistics, with many clinics offering airport pickups and accommodation arrangements.
What patients don’t like:
- Language barrier. Some patients encounter language barriers, although most clinics offer translation services.
- Waiting time. Despite efficient services, patients sometimes complain about the long waiting times due to high demand.
- Distance. For some, the distance to travel to Turkey for treatment can be an inconvenience.
How Much Does Immunotherapy for prostate cancer Cost in Turkey?
The average price of Immunotherapy for prostate cancer in Turkey is $11500, the minimum price is $10000, and the maximum price is $13000.
| Turkey | Austria | Spain | |
|---|---|---|---|
| Immunotherapy for prostate cancer | from $10000 | - | from $1042 |
| The total cost is calculated individually. It may range depending on your medical issue, doctor's qualification, procedure complexity and related complications (if they occur). You’ll get the exact price for a plastic surgery procedure after a consultation with a doctor. | |||
Below average
Above average
No-Cost Review of Your Immunotherapy for prostate cancer Medical Records
Upload Your Medical Records
Get Rapid Translation for Free
Receive Personalized Recommendations
Discover the Best Immunotherapy for prostate cancer Clinics in Turkey: 21 Verified Options and Prices
Check the hospital ranking based on requests and 6 reviews to pick the right Immunotherapy for prostate cancer clinic for you.
Highest-Rated Clinic for Immunotherapy for prostate cancer
Turkey,
Istanbul
doctor
Yesim Yildirim
Leading doctor for Immunotherapy for prostate cancer
Clinical oncologist
20 years of experience
Anadolu Medical Center is a multidisciplinary facility providing American treatment standards at affordable prices in Istanbul (Turkey). Anadolu affiliates with the Johns Hopkins Hospital, one of the best medical facilities in the USA.
Oncology, hematology oncology, urology, neurosurgery, women's health, , and check-up are the leading specialties in Anadolu Hospital.
The medical center is among the Top 10 hospitals in the world according to the Medical Travel Quality Alliance (MTQUA), an international organization that promotes excellent standards of health services for medical tourists.
Patients from the United States, the United Kingdom, Romania, Bulgaria, and Azerbaijan choose Anadolu Medical Center.
Summary about Anadolu from patients' reviews:
The Anadolu Clinic is a highly-regarded medical facility located on the coast of the marble sea. It is renowned for its professionalism, cleanliness, and attention to detail. The staff is polite, attentive, and responsive to patients' needs. Highly-trained and skilled doctors are available for comprehensive examinations and treatments, and the recovery room is bright and comfortable with a beautiful view. Patients have benefited from the services of an excellent translator, Elmira, and the support of coordinators Zakhida, Bakhtygul, and Amina, Gayana. The clinic also offers a transfer service from the airport to the hotel and back, as well as booking a hotel conveniently located 10-15 minutes away. Anadolu is the perfect choice for a successful treatment and recovery.
Top 5 Anadolu Advantages:
- Highly skilled and experienced medical staff
- Advanced equipment
- Personal coordinators and interpreters
- Pleasant atmosphere
- Wide range of medical services and treatments
Read more details
accreditations:
+5
Anonymous
• Oct 4, 2023
Hello, I am from Uzbekistan, from Tashkent, many thanks to Bookimed, when we didn’t know where to turn, where to find a good clinic, they helped me choose a very good clinic and the doctors talked to the patients themselves, they were all happy with the treatments, I have never seen an unhappy patient.
Price
upon request
Clinic
Doctors
Reviews
Turkey,
Istanbul
Valued Med Hub Hospitals is a private multi-specialty medical center located in Istanbul, Turkey. The team specializes in neurosurgery, orthopedics, ophthalmology, organ transplant, and plastic surgery. Valued Med Hub Hospitals serves both adults and children. Patients from Europe & Commonwealth, CIS countries, and Arab League States visit the clinic most often.
Read more details
accreditations:
Anonymous
• Sep 15, 2024
VMH hospitals. I had an operation there, and it was successful. I would like to thank VMH hospitals very much and recommend them to everyone.
Price
upon request
Clinic
Reviews
Turkey,
Istanbul
Memorial Şişli Hospital in Istanbul is the largest multidisciplinary medical center in Istanbul. It is the 1st hospital in Turkeу and the 21st in the world accredited by Joint Commission International (JCI) for the high quality of treatment.
Memorial Şişli specialties are the following: oncology, transplant, , neurosurgery, weight loss surgery, including gastric lap banding, and organ transplant. The success rate of organ transplant at Memorial is 90%.
Patients from 92 countries choose Memorial Şişli for treatment annually.
Read more details
accreditations:
Неля
• Aug 26, 2019
This is a kind, responsive, attentive, punctual person! Thank you Memorial Clinic for the organization, support, good news! I recommend this wonderful clinic to everyone!
Price
upon request
Clinic
Reviews
We're rated “Excellent” on TrustPilot
At Bookimed, we put your health first with safe and easy solutions. Our quality care is proven by excellent reviews from patients.
Turkey,
Istanbul
Medipol University Hospital is one of the largest multi-specialty medical institution in Turkey. Daily, over 1,200 patients trust their health to Medipol's experts. The hospital is equipped with advanced technologies, i.e, Da Vinci Surgical System, Cyber and Gamma Knives. Doctors specialize in cancer, neurological, and cardiovascular treatment. Organ transplantation, transplant and are among key specialties of the hospital.
Read more details
accreditations:
Bohdan Bashtanar
• Apr 11, 2019
Many thanks to the doctors, staff for your work, professionalism, Help, good nature. You give people and children a chance for a full life.
Yours faithfully, the director of the charity foundation Lyubov Lyubushkina
Price
upon request
Clinic
Reviews
Turkey,
Istanbul
Hisar Hospital Intercontinental is a multi-specialty medical center in Turkey, Istanbul.
The medical center specializes in pediatric and adult cardiovascular surgery, orthopedics, oncology, weight loss surgery, including gastric band surgery, and check-ups. Hisar Intercontinental Hospital serves only adults. 250,000 patients choose Hisar Intercontinental Hospital to get medical care every year. Hisar Hospital is certified by JCI (Joint Commission International) that confirms compliance with international standards of treatment quality and safety.
Patients from CIS, Balkans and African countries choose Hisar Hospital for medical care.
Read more details
accreditations:
Аl'bina Левченко
• Nov 13, 2023
Excellent transfer, even from the bus station, hotel included in the price, almost like a separate apartment, very smiling and always helpful staff, excellent translator, clinic administrator. Liked everything. They expect me to check in in six months. I will definitely go to them.
Price
upon request
Clinic
Reviews
Turkey,
Istanbul
Memorial Hospital Bahçelievler (Memorial Bahçelievler Hastanesi) is a multidisciplinary medical center in Istanbul with an eco-friendly design. There are a lot of green areas on the hospital territory, which contribute to patients’ psychological comfort and their speedy recovery.
The medical facility specializes in oncology treatments, cardiovascular surgery, orthopedics, brain surgery, urology, gynecology, general and robotic surgery.
Read more details
accreditations:
Ivanka
• Oct 6, 2023
We are more than grateful to our coordinator from Bookimed dr. Hanna. She has been our helper and supporter every step of the way. I highly recommend to take a contact with her if you need help for treatment in another country. She is wonderful and supportive and organise ting and consultation with doctors pretty fast. We get a good help in Memorial hospital thanks to her and her assistance.
Price
upon request
Clinic
Reviews
Turkey,
Istanbul
Memorial Atasehir Hospital is a private multidisciplinary hospital in Istanbul which belongs to the large Memorial Healthcare Group. The Memorial Atasehir specialties are organ transplant (with 99.5% success rate for liver and 99% for kidney), (65% success rate), oncology, cardio- and neurosurgery.
The hospital has Joint Commission International (JCI) certificate for the compliance with international treatment standards, quality, and safety. JCI is a global organization that controls the quality of medical services worldwide.
Read more details
accreditations:
Айдин
• Jul 31, 2020
Hello everybody. Thanks to the Clinic for a successful operation. To the Neurosurgeon Mustafa Onaz and Professor Gohan. We are diagnosed with Brain cancer, the last stage, malignant. The tumor was twice as large. They saved my husband's life. Masha Allah. The operation was 8-9 hours. they deleted everything, I consider this a record. It was a difficult operation. Well done. At our KZ they could not remove everything that was, only a small part was removed and that's it. I bow to you. At the expense of the clinic. Service At the Highest Level. Another razzzzz Many thanks to Mustafa Onaz. We love you. A doctor from God. He needs OsKar ❤️❤️❤️ Aidana Amanshieva
Price
upon request
Clinic
Reviews
Turkey,
Istanbul
Liv Hospital Ulus is a multi-specialized medical center located in Istanbul.
Orthopedics, cancer treatment, weight loss surgery, neurosurgery, heart surgery and regenerative medicine are the leading specialties in the hospital.
Liv is a smart hospital with innovative medical technologies available: da Vinci robot-assisted system for the surgeries, MAKOplasty for knee replacement, YAG Laser for vascular surgery, virtual angiography for cardiac diagnostics, etc.
Liv Hospital in Istanbul is a popular weight loss surgery clinic in Turkey — patients lose 71% of their excess weight in a year.
Read more details
accreditations:
+3
Anonymous
• Sep 9, 2021
We went to the clinic for rectal adecarcenoma. Bookimed coordinator Ekaterina promptly and professionally helped organize the trip. Upon arrival at the airport, we were met by a car from Liv Hospital, taken to the booked hotel. Each transfer from the hotel to the clinic and back was carried out practically without delay. The examination took place within the agreed time and price, and a course of treatment was prescribed. What will be the results of treatment, time will tell
Price
upon request
Clinic
Reviews
Turkey,
Istanbul
accreditations:
Price
upon request
Clinic
Reviews
Turkey,
Istanbul
Medipol Bahçelievler Hospital is a private multi-specialty medical center located in Istanbul, Turkey. The team is dedicated to cardiology, oncology, heart surgery and surgery. Medipol Bahçelievler Hospital, part of the esteemed Medipol Health Group, is a leader in healthcare with 441 beds and JCI accreditation. Our focus on advanced technologies, such as TrueBeam STx and Halcyon in Radiation Oncology, sets us apart. Renowned for comprehensive cancer care, integrating PET-CT and SPECT-CT imaging, we prioritize patient comfort with modern maternity units. Positioned in Istanbul's Bahçelievler district, we cater to global patients, contributing to health tourism. Medipol Bahçelievler Hospital serves both adults and children. 600000 patients choose Medipol Bahçelievler Hospital to get medical care every year. Patients from Europe & Commonwealth, Arab League States, and Russian-Speaking Countries visit the clinic most often.
Read more details
accreditations:
Anonymous
• Jul 25, 2024
the medical team also the best and helpful group of doctors in the hospital and it is good international hospital in istanbul turkey
thank you very much
Ashley Kesete
————————-
Price
upon request
Clinic
Reviews
Your Medical Travel Guide: Essential Tips and Advice
question
explanation
How many days do I need to stay in Turkey?
1 day
Our Doctors
accreditations:
Professor Yesim Yıldırım has been working as a medical oncology specialist at Anadolu Medical Center since 2011. She is a member of the European Society of Medical Oncology (ESMO).
She specializes in the cancer immunotherapy and targeted therapies, diagnostics and treatment of malignant neoplasms of various localizations, especially breast cancers, gastrointestinal cancers and lung cancers.
Also she wrote more than 80 international and national publications, abstracts and books ( co-author in ‘Handbook of Advanced Cancer Care Treatment’ and ‘Precision medicine in cancer and non-communicable disease).
Yesim Yildirim is one of the outstanding specialists in the area of medical oncology.
Not only a doctor, but also a scientist and lecturer in Halic University (Istanbul: Turkey). She is a member of several well-known associations: ESMO - European Society of Medical Oncology, ESO - European School of Oncology and so forth.
Nowadays she is currently working in Anadolu Medical Centre at a position of Professor.
Education: In 1999 Dr. Yesim Yıldırım graduated from Hacettepe University Medical School and started internal medicine fellowship in Gazi University. After finishing internal medicine she subsequently started her oncology career in Baskent University and became medical oncologist in 2007. During her academic journey she was awarded by numbers of grants and scholarships.
Academic experience:
Obtained a grade of minor assistant to the Medical Oncology Hospital Division after gaining a scholarship of Middle East Cancer Consortium and attending an advanced oncology tuition courses at Rambam Medical Centre in Haifa, Israel;
In 2010 achieved an academic rank of Assistant Professor of internal diseases at Acibadem University School of Medicine;
Gained the attestation certificate from ESMO examination (2010);
Was conferred a scholastic Associate Professor degree in medical oncology after completing her academic studies in 2011;
Participated to the training course in Melanoma and Kidney Cancer Clinic at Mount Vernon Cancer Center Immunooncology Clinic, London, UK;
Successfully finished MBA program in Healthcare Management in Bilgi University, Istanbul;
In 2021 achieved an academic rank of Professor in Haliç University, Istanbul.
Improving of practical qualification:
Sivas Numune Hospital (compulsory service for government);
Acibadem Kozyatagi Hospital;
Acibadem University of Medicine;
Anadolu Medical Centre, Istanbul, Turkey.
Language: English, Russian (B1 level), Turkish
Read more
Hisar Intercontinental Hospital
Mustafa Solak, M.D., who was born in 1978, was graduated from School of Medicine, Hacettepe University. He completed his residency education in İstanbul Sisli Etfal Teaching and Research Hospital and completed his fellowship in Cancer Institute of Hacettepe University.
He has dealt with many cases of Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, Gastrointestinal Cancers.
FIELDS OF MEDICAL INTEREST
Breast cancer
Testicular Cancer
Ovarian Cancer
Lung Cancer
Head & Neck Cancers
Gastrointestinal cancers
EDUCATİON:
Bachelor's: Hacettepe University Faculty of Medicine
Specialization: Istanbul Sisli Etfal Training and Research Hospital
Minor Specialization: Hacettepe University Cancer Institute
INSTITUTIONS WHERE EDUCATION AND WORKED
The University of Texas MD Anderson Cancer Center
Hitit University Corum Training Hospital
Medical Park Hospital
Read more
accreditations:
PROFESSIONAL EXPERIENCE2011-2012Erzurum Koprukoyu State HospitalDepartment: General Medicine2012-2017Istanbul University Cerrahpaşa Medical FacultyDepartment: Internal Medicine06/2017-10/2017Istanbul Gaziosmanpasa Taksim Training and Research HospitalDepartment: Internal Medicine10/2017-11/2018Istanbul University Istanbul Medical FacultyDepartment: Allergy and Immunology Fellowship2018/2022Istanbul University Oncology InstituteDepartment: Medical Oncology Fellowship2022-2023Tekirdag City HospitalDepartment: Medical Oncology Specialist2023-presentIstanbul Medipol University Medipol Bahcelievler Private HospitalDepartment: Medical Oncology Assoc. Prof. EDUCATION2005-2011Medical EducationSivas Cumhuriyet University Medical Faculty, Sivas, Turkey2012-2017Internal MedicineIstanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey2017-2018Allergy-Immunology FellowshipIstanbul University Istanbul Medical FacultyDepartment of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey2018-2022Medical Oncology FellowshipIstanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey2022ESMO Board Certification in Medical Oncology10th September 2022 in Paris, France.2023Medical Oncology Assoc. Prof.Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey INTERNATIONAL CLINICAL TRIALS:1. Astefania - ROCHETitle: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative TherapyRole: Subinvestigator2. PFİZERTitle: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLCRole: Subinvestigator3. RECITE - AMGENTitle: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerRole: Subinvestigator4. NAVIGATE - BAYERTitle: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsRole: Subinvestigator5. RUBY - Tesaro (PRA)Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial CancerRole: Subinvestigator6. ENGOT-ov43/GOG-3036 - MSDTitle: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)Role: Subinvestigator7. ASTRA ZENECATitle: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.Role: Subinvestigator8. ROSY-O - ASTRA ZENECATitle: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibRole: Subinvestigator INTERNATIONAL PUBLICATIONSI. Published journal articles indexed by SCI, SSCI, and AHCIWeekly Paclitaxel in Classic Kaposi SarcomaAuthors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.Journal: Medicine, 102(5)Carboplatin Desensitization in Ovarian CarcinomaAuthors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.Journal: Medicine, 101(45), e31726High-Dose Chemotherapy for Ewing’s SarcomaAuthors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.Journal: Medicine, 101(49), e32213Multidrug Refractory TFE3(+) Renal Cell CarcinomaAuthors: Paksoy, Nail, et al.Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221Crizotinib Efficacy in NSCLC with MET AlterationsAuthors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.Journal: Medicine, 101(50), e32368Clinicopathological Features in ALK Mutant NSCLCAuthors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.Journal: Medicine, 101(34)PSMA-Based Tumor Burden in Prostate CancerAuthors: HAS SIMSEK, Duygu, et al.Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690Atezolizumab in Metastatic Urothelial CarcinomaAuthors: TURAL, Deniz, et al.Journal: European Urology Focus, 2021, 7.5: 1061-1066Pulmonary Sarcomatoid CarcinomaAuthors: FERHATOGLU, Ferhat, et al.Journal: Oncology Research and Treatment, 2021, 44.11: 590-601Prognostic Factors in Atezolizumab-Treated Urothelial CarcinomaAuthors: TURAL, Deniz, et al.Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513Atezolizumab with Chemotherapy in Small Cell Lung CancerAuthors: GÜRBÜZ, Mustafa, et al.Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic CancerAuthors: AY, Seval, et al.Journal: Journal of Chemotherapy, 2022, 1-7Trastuzumab Emtansine in Older HER2-Positive Breast Cancer PatientsAuthors: CIL, Ibrahim, et al.Journal: Tumori Journal, 2022, 108.1: 19-25Real-Life Efficacy of Osimertinib in Advanced NSCLCAuthors: HIZAL, Mutlu, et al.Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508ALK-Positive Cells Percentage and Alectinib EfficacyAuthors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148Real-World Data on Alectinib in ALK-Positive NSCLCAuthors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.Journal: Future Oncology, 18(23), 2573-2582Prognostic Factors in Metastatic RCC with T790M MutationAuthors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsFLOT Regimen in Metastatic Gastric CancerAuthors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.Journal: Journal of Cancer Research and TherapeuticsDesensitization Protocol in Lenalidomide Hypersensitivity ReactionsAuthors: DEMIR, Semra, et al.Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397Factors Associated with Diagnostic Skin Test Positivity in PPI HypersensitivityAuthors: ÖZDEMIR, Seçil Kepil, et al.Journal: Allergy, 2019, 74.6: 1187-1190Efficacy of Capecitabine and Temozolomide in Neuroendocrine TumorsAuthors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.Journal: The Oncologist, oyad257Subsequent Treatments in Hormone-Positive Breast Cancer ProgressionAuthors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.Journal: BMC cancer, 23(1), 192Termination of Trastuzumab in HER2-Positive Metastatic Breast CancerAuthors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.Journal: Scientific Reports, 13(1), 8779Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast CancerAuthors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.Journal: Journal of Cancer Research and Clinical Oncology, 1-9Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast CancerAuthors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.Journal: European Journal of Breast Health, 19(2), 128Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast CancerAuthors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.Journal: Future Oncology, 19(10), 727-736Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma PatientsAuthors: Dogan, I., Paksoy, N., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsSingle-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma PatientsAuthors: Dogan, I., Paksoy, N., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsOutcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain MetastasesAuthors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsFLOT Regimen in First-Line Treatment of Metastatic Gastric CancerAuthors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.Journal: Journal of Cancer Research and TherapeuticsPrognostic Factors of Perioperative FLOT Regimen in Operable Gastric CancerAuthors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.Journal: [Not specified]Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi SarcomaAuthors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.Journal: Medicine, 102(39), e35383Comparison of Second-Line Treatments in Metastatic Renal Cell CarcinomaAuthors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.Journal: Medicine, 102(41), e35245Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGYPredictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of PulmonologyLaterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye Thesis:Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combinationAuthors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group studyAuthors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancerAuthors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)Efficacy of temozolomide in pretreated patients with metastatic sarcomaAuthors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumorsAuthors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcomaAuthors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastasesAuthors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinomaAuthors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk studyAuthors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiencesAuthors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)
Read more
Updated: 7/2/2024
The content accuracy and quality have been checked by Bookimed Medical Advisory Board
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.
6 Recent Immunotherapy for prostate cancer Reviews in Turkey: Check Real Patient Experience
All reviews are checked by Bookimed team to ensure they are real. Clinics or doctors cannot add, edit, or delete reviews.
Bookimed editorial policy
Bookimed, a leading global medical tourism platform, is committed to helping clients looking for Immunotherapy for prostate cancer by offering expert assistance and trustworthy medical solutions for every situation. Smart automatic ranking system is used to compose transparent clinic listings, meticulously maintained by a data scientist using AI for accuracy. The platform guarantees authenticity by publishing reviews from real patients after their treatments. Bookimed offers comprehensive medical solutions, with updates from clinics to ensure trustworthiness. The content about Immunotherapy for prostate cancer, crafted by experienced medical authors and reviewed by specialists, adheres to Bookimed"s Editorial Guidelines, reflecting the platform"s commitment to delivering high-quality and clear health information. For more details or inquiries, feel free to contact us at marketing@bookimed.com or learn more about us and our mission here.
Bookimed CEO Quality Assurance